Acute Myelogenous Leukemia  >>  dociparstat sodium (CX-01)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dociparstat sodium (CX-01) / Cantex Pharma, Chimerix
NCT04571645: Dociparstat in Combination With Standard Chemotherapy for the Treatment of Acute Myeloid Leukemia

Terminated
3
9
US
Dociparstat, DSTAT, CX-01, 2-0,3-0 desulfated heparin, ODSH, dociparstat sodium, Control, 0.9% Normal Saline, Normal saline, Sodium chloride 0.9%
Chimerix
Acute Myeloid Leukemia
05/22
05/22

Download Options